Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - enoxaparinum natricum - soluzione iniettabile - enoxaparinum natricum 120 mg corresp. 12000 u.i. anti-xa, aqua ad iniectabile q.s. ad solutionem pro 0.8 ml. - anticoagulante - biotechnologika

Switzerland - Italian - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - enoxaparinum natricum - soluzione iniettabile - enoxaparinum natricum 150 mg corresp. 15000 u.i. anti-xa, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - anticoagulante - biotechnologika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - enoxaparinum natricum - solution injectable - enoxaparinum natricum 300 mg corresp. 30000 u.i., conserv.: alcohol benzylicus 45 mg, aqua ad iniectabile q.s. ad solutionem pro 3 ml. - anticoagulant - biotechnologika

Switzerland - German - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - ticagrelorum - filmtabletten - ticagrelorum 90 mg, mannitolum, calcii hydrogenophosphas dihydricus, carboxymethylamylum natricum a, hydroxypropylcellulosum, magnesii stearas, Überzug: hypromellosum, e 171, talcum, macrogolum 400, e 172 (flavum), pro compresso obducto corresp. natrium 0.38 mg. - thrombozytenaggregationshemmung in kombination mit acetylsalicylsäure - synthetika

Switzerland - German - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - ticagrelorum - filmtabletten - ticagrelorum 60 mg, mannitolum, calcii hydrogenophosphas dihydricus, carboxymethylamylum natricum a, hydroxypropylcellulosum, magnesii stearas, Überzug: hypromellosum, e 171, macrogolum 400, e 172 (nigrum), e 172 (rubrum), pro compresso obducto corresp. natrium 0.25 mg. - thrombozytenaggregationshemmung in kombination mit acetylsalicylsäure - synthetika

Switzerland - German - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - ticagrelorum - schmelztabletten - ticagrelorum 90 mg, mannitolum, cellulosum microcristallinum, crospovidonum, xylitolum, calcii hydrogenophosphas, natrii stearylis fumaras, hydroxypropylcellulosum, silica colloidalis anhydrica, pro compresso corresp. natrium 0.53 mg. - thrombozytenaggregationshemmung in kombination mit acetylsalicylsäure - synthetika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - ticagrelorum - comprimés pelliculés - ticagrelorum 90 mg, mannitolum, calcii hydrogenophosphas dihydricus, carboxymethylamylum natricum a, hydroxypropylcellulosum, magnesii stearas, Überzug: hypromellosum, e 171, talcum, macrogolum 400, e 172 (flavum), pro compresso obducto corresp. natrium 0.38 mg. - thrombozytenaggregationshemmung en association avec l'acide acétylsalicylique - synthetika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - ticagrelorum - comprimés pelliculés - ticagrelorum 60 mg, mannitolum, calcii hydrogenophosphas dihydricus, carboxymethylamylum natricum a, hydroxypropylcellulosum, magnesii stearas, Überzug: hypromellosum, e 171, macrogolum 400, e 172 (nigrum), e 172 (rubrum), pro compresso obducto corresp. natrium 0.25 mg. - thrombozytenaggregationshemmung en association avec l'acide acétylsalicylique - synthetika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - ticagrelorum - les comprimés orodispersibles - ticagrelorum 90 mg, mannitolum, cellulosum microcristallinum, crospovidonum, xylitolum, calcii hydrogenophosphas, natrii stearylis fumaras, hydroxypropylcellulosum, silica colloidalis anhydrica, pro compresso corresp. natrium 0.53 mg. - thrombozytenaggregationshemmung en association avec l'acide acétylsalicylique - synthetika